Andres Gomez: In my view, the most important issue for AML patients worldwide is lack of access to comprehensive testing.
Quoting Andres Gomez, Associate Professor at UANL Monterrey, Mexico, on X/Twitter:
“I like the paper in The Lancet Haematology on standardizing AML by experts in western HICs. In my view, the most important issue for AML patients worlwide is lack of access to comprehensive testing. Without this, any classification is moot. More often than not we are flying blind.
We all should recognize the elephant in the room. We should measure the problem and develop strategies to make molecular biology affordable and feasible for persons worldwide. The authors scratch the surface below:
For the article, click here.
Then we can have the luxury of following the ICC/ELN WHO labyrinth of AML/MDS diagnosis. We are working on it but Big Lab like making big bucks like their cousins in pharma and definitely does not make it easy….”
Source: Andres Gomez/Twitter
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023